-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Hwb+89ZD72h8/6Lr6r4bwXeQnZ/vJvatDk/3cP+6vvTd/2yjJi/wmWNhB9Otqz1p
 ji5H6O7Vz0qyRmgFdA9xRw==

<SEC-DOCUMENT>0000919574-95-000591.txt : 19951124
<SEC-HEADER>0000919574-95-000591.hdr.sgml : 19951124
ACCESSION NUMBER:		0000919574-95-000591
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19951122
SROS:			NASD

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DURAMED PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000799903
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				112590026
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-38106
		FILM NUMBER:		95596008

	BUSINESS ADDRESS:	
		STREET 1:		7155 E KEMPER RD
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45249
		BUSINESS PHONE:		5137319900

	MAIL ADDRESS:	
		STREET 1:		5040 LESTER ROAD
		STREET 2:		5040 LESTER ROAD
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45213

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EVEREST CAPITAL LTD
		CENTRAL INDEX KEY:			0000922216
		STANDARD INDUSTRIAL CLASSIFICATION:	UNKNOWN SIC - 0000 [0000]
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		CORNER HOUSE 20 PARLIAMENT ST
		STREET 2:		P O BOX HM 2458
		CITY:			HAMILTON
		STATE:			D0

	MAIL ADDRESS:	
		STREET 1:		SEWARD & KISSEL
		STREET 2:		1 BATTERY PARK PLAZA
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10004
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<TEXT>




<PAGE>

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934

Amendment No.:  *

Name of Issuer:  Duramed Pharmaceuticals, Inc.

Title of Class of Securities:  Common Stock, Par Value $0.01 per
share

CUSIP Number:  0002663541

          (Name, Address and Telephone Number of Person
       Authorized To Receive Notices and Communications)  

  Mr. Dimitrijevic, c/o Everest Capital Limited, Corner House,
           20 Parliament St., Hamilton HM 12, Bermuda

     (Date of Event which Requires Filing of this Statement)

                       September 28, 1995

If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box [   ].

Check the following line if a fee is being paid with this
statement  X.  (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
class.  See Rule 13d-7).

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).



<PAGE>

CUSIP No. 0002663541

1.  Name of Reporting Person
    S.S. or I.R.S. Identification No. of Above Person

         Everest Capital Limited

2.  Check the Appropriate Box if a Member of a Group

         a.   
         b.   

3.  SEC Use Only

4.  Source of Funds

         AF

5.  Check if Disclosure of Legal Proceedings is Required Pursuant
    to Items 2(d) or 2(e)

6.  Citizenship or Place of Organization

         Bermuda

Number of Shares Beneficially Owned by Each Reporting Person
With:

7.  Sole Voting Power:

         244,800

8.  Shared Voting Power:


9.  Sole Dispositive Power:

         244,800

10. Shared Dispositive Power:


11. Aggregate Amount Beneficially Owned by Each Reporting Person

         244,800

12. Check Box if the Aggregate Amount in Row (11) Excludes
    Certain Shares





<PAGE>

13. Percent of Class Represented by Amount in Row (11)

         3.0%

14. Type of Reporting Person

         CO

The purpose of this Schedule 13D is to report that Everest
Capital Limited's (the "Reporting Person") ownership of the
Common Stock, Par Value $0.01 (the "Shares") in Duramed
Pharmaceuticals, Inc. (the "Issuer") exceeded 5.0%.  The
Reporting Person currently beneficially owns 3.0% of the Shares
outstanding.

Item 1.  Security and Issuer

         The title of the class of equity securities to which
         this statement relates is:  Common Stock, Par Value
         $0.01 per share, in Duramed Pharmaceuticals, Inc.

         The name and address of the principal executive and
         business office of the Issuer is:

         Duramed Pharmaceuticals, Inc.
         7155 East Kemper Road
         Cincinnati, Ohio  45249

Item 2.  Identity and Background

         (a)  Everest Capital Limited

         (b)  Corner House, 20 Parliament Street, Hamilton
              HM 12, Bermuda

         (c)  The principal business of the Reporting Person is
              investment management for Everest Capital Fund,
              L.P., a Delaware limited partnership in which the
              Reporting Person serves as General Partner and
              Everest Capital International Ltd., a corporation
              organized under the laws of the British Virgin
              Islands.

         (d)  During the last five years, neither the Reporting
              Person nor any person affiliated with the Reporting
              Person has been convicted in any criminal
              proceeding, excluding traffic violations or similar
              misdemeanors.

         (e)  During the last five years, neither the Reporting
              Person nor any person affiliated with the Reporting



<PAGE>

              Person has been a party to a civil proceeding of a
              judicial or administrative body of competent
              jurisdiction as a result of which it or such person
              is subject to a judgment, decree or final order
              enjoining future violations of, or prohibiting or
              mandating activities subject to, federal or state
              securities laws or finding any violation with
              respect to such laws.

         (f)  The Reporting Person is a corporation organized
              under the laws of Bermuda.

Item 3.  Source and Amount of Funds or Other Consideration.

         As described in Item 2(a) above, the Reporting Person
         exercises investment discretion with respect to the
         capital of Everest Capital Fund, L.P. and Everest
         Capital International Ltd.  In that capacity, the
         Reporting Person purchased the Shares which are the
         subject of this Schedule 13D on behalf of Everest
         Capital Fund, L.P. and Everest Capital International
         Ltd. in open market transactions.

Item. 4  Purpose of Transactions.

         The Shares held by the above-mentioned entities were
         acquired for, and are being held for, investment
         purposes.  The acquisitions of the Shares described
         herein were made in the ordinary course of the Reporting
         Person's business or investment activities, as the case
         may be.  The Reporting Person, on behalf of the above-
         mentioned entities, reserves the right to purchase
         additional Shares or to dispose of the Shares in the
         open market or in privately negotiated transactions or
         in any other lawful manner in the future.


Item 5.  Interest in Securities of Issuer.

         (a)  The Reporting Person beneficially owns 244,800 of
              the Shares Par Value $0.01 per share.  Based upon
              the Issuer's 10Q dated September 30, 1995, there
              are currently 8,054,209 outstanding Shares.
              Therefore, the Reporting Person is deemed to
              beneficially own 3.0% of the Issuer's outstanding
              Shares.

         (b)  The Reporting Person has sole power to vote and to
              dispose of the 244,800 Shares.




<PAGE>

         (c)  All transactions in the Shares effected by the
              Reporting Person during the past sixty days were
              effected in open-market transactions and are set
              forth in Exhibit A hereto.

         (d)  No other person is known to have the right to
              receive or the power to direct the receipt of
              dividends from, or the proceeds from the sale of
              the Shares.

         (e)  Not applicable.


Item 6.  Contracts, Arrangements, Understandings or
         Relationships with Respect to Securities of the Issuer

         In connection with the Reporting Person's arbitrage
         strategy, the Reporting Person has entered into
         arrangements to sell 318,600 of the Issuer's Shares.
         Except as described herein, there are no contracts,
         arrangements, understandings or relationships between
         the persons named in Item 2 hereof or between such
         persons and any other person with respect to any
         securities of the Issuer.

Item 7.  Material to be Filed as Exhibits.

         Exhibit A.   Schedule of Transactions in the Shares
                      made by the Reporting Person.






<PAGE>

         Signature

         After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set
forth in this statement is true, complete and correct.

November 22, 1995       
____________________________
Date


/s/ Marko Dimitrejevic      
____________________________
Signature



Marko Dimitrejevic/President
____________________________
Name/Title



<PAGE>

                         EXHIBIT A

                 SCHEDULE OF TRANSACTIONS

                                       Price Per Share
                                         (Excluding
Date               Shares Acquired       Commission)
____               _______________     _____________

8/22/95                120,000              15.57

8/23/95                125,000              15.16

8/24/95                 40,000              16.13

8/25/95                 60,000              16.00

9/18/95                 20,000              15.63

9/28/95                 80,000              14.82

10/02/95                17,400              14.44

10/04/95                (2,200)             12.94

10/05/95               (12,200)             12.82

10/09/95               (14,400)             13.75

11/08/95              (125,000)             15.63

11/16/95               (38,600)             14.65

11/17/95               (13,200)             14.10

11/21/95               (12,000)             13.44

















00119001.CD5


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
